Target is expanding its push into higher-end beauty with a new specialty-style concept that the retailer says is part of its broader effort to return to growth.

The Minneapolis-based retailer said Target Beauty Studio will launch Sept. 10 in more than 600 stores nationwide and on Target.com, bringing together more than 1,600 products from 90 prestige, emerging and international brands. More than two-thirds of the brands will be new to Target.

The rollout represents a notable expansion of Target’s beauty assortment while adding features more commonly associated with specialty beauty retailers, including dedicated beauty advisers, product testing, rotating product showcases and personalized recommendations.

Target said the new concept is one example of the investments it is making in merchandise and the in-store shopping experience as part of its plans to return to growth. The company operates more than 2,000 U.S. stores.

WALMART AGREES TO PAY $50M SETTLEMENT OVER ALLEGATIONS ITS PHARMACIES FILLED ILLEGAL OPIOID PRESCRIPTIONS

“When guests shop for beauty, they want to pick up their standbys while also exploring what’s new and trending, and Target Beauty Studio is designed with that mix in mind,” Amanda Nusz, Target’s senior vice president of merchandising, essentials and beauty, said in a statement. “It’s an inspiring destination to discover what’s new, now and next in beauty — and a powerful example of how our merchandising authority comes to life through an elevated guest experience.”

Ticker	Security	Last	Change	Change %
TGT	TARGET CORP.	163.18	-2.75	-1.66%

The assortment will span skincare, makeup, haircare, fragrance, bath and body products, nail care and sun care. Brands joining Target include Sunday Riley and First Aid Beauty in skincare, Briogeo and Nioxin in haircare and several Korean beauty brands, including Amuse, Kaja and Rom&nd.

The announcement comes after the retailer concluded its shop-in-shop partnership with Ulta Beauty. The partnership rolled out in August 2021 and ended this month.

Target is also adding products from international brands, including Mexican beauty company SARELLY and French nail care brand Manucurist, while offering premium fragrances, styling products, sun care and self-tanning products.

Stores with Target Beauty Studio will feature a central display that rotates several times a year to highlight brands, collaborations and seasonal products. The retailer will also offer a dedicated assortment of miniature products designed to give shoppers a lower-cost way to try new items.

The company is tying the concept to its Target Circle loyalty program through exclusive offers and experiences. Target said the first 100 guests at most stores during a Sept. 26 promotional event will receive a Target Circle bonus that can be used to shop Beauty Studio in stores and online.

CLICK HERE TO GET FOX BUSINESS ON THE GO

Target said Beauty Studio will continue to evolve with new brands and products, while its existing beauty assortment will remain alongside the new concept.

Northwest Naturals is recalling nearly 2,000 pounds of raw cat and dog food after federal testing found salmonella and Listeria monocytogenes contamination in two chicken products distributed nationwide.

The Portland, Oregon-based company is voluntarily recalling 53 cases, or 1,272 pounds, of Northwest Naturals Frozen Chicken Recipe and 19 cases, or 684 pounds, of Northwest Naturals Frozen Raw Diet for Dogs Chicken Recipe, according to a company announcement posted Friday by the Food and Drug Administration.

The recall covers a total of 1,956 pounds of product.

The 2-pound Frozen Chicken Recipe, which is marketed as cat food and a protein topper for dogs, tested positive for salmonella. The 6-pound Frozen Raw Diet for Dogs Chicken Recipe tested positive for both salmonella and Listeria monocytogenes, according to the announcement.

NEARLY 25K POUNDS OF FROZEN BUFFALO CHICKEN RECALLED OVER INSPECTION LAPSE

The contamination was identified after product samples were collected and tested by the FDA. No illnesses had been reported in connection with the recall as of Aug. 28, the company said.

The affected 2-pound Frozen Chicken Recipe bears lot number B-5, a best-by date of Jan. 26, 2028, and UPC 087316384956. The affected 6-pound Frozen Raw Diet for Dogs Chicken Recipe bears lot number B-19, a best-by date of Jan. 25, 2028, and UPC 087316380392. The recalled products were distributed to retail stores nationwide.

Salmonella and Listeria monocytogenes can sicken animals that eat contaminated products and can also pose a risk to people who handle the food or come into contact with contaminated surfaces, according to the recall notice.

Pets infected with either bacteria may experience lethargy, diarrhea or bloody diarrhea, fever, vomiting, decreased appetite, and abdominal pain. Infected animals can also carry the bacteria and potentially spread them to people or other animals.

Consumers who purchased the affected products are being advised to stop feeding them to their pets and return the unused portion to the place of purchase for a full refund.

CLICK HERE TO GET FOX BUSINESS ON THE GO

Northwest Naturals also advised consumers handling raw pet food to wash their hands thoroughly and clean and sanitize bowls, utensils, surfaces and storage areas that come into contact with the products.

FOX Business reached out to Northwest Naturals for additional comment.

The much-awaited initial public offering (IPO) of the National Stock Exchange of India (NSE) could be closer to launch, leaving investors with two routes to gain exposure to the exchange: buy its shares in the pre-IPO, unlisted market or wait for the public issue.

Securities and Exchange Board of India (SEBI) chairman Tuhin Kanta Pandey on August 27 said the market regulator was close to clearing the draft red herring prospectus (DRHP) filed by NSE, the world’s largest derivatives exchange by trading volume.

NSE filed its draft prospectus in June for an IPO that will comprise entirely of an offer for sale (OFS), allowing existing shareholders to pare their stakes. The exchange had initially expected SEBI clearance for its DRHP by early August. The timeline was subsequently pushed back by around three weeks following changes to the roster of selling shareholders, with SBI Capital Markets being added.

At the top end of the marketed valuation of Rs 5.26 lakh crore ($55 billion), NSE would rank sixth among global exchange operators by market capitalisation, narrowly behind London Stock Exchange Group Plc and ahead of Nasdaq Inc, according to Bloomberg.

NSE unlisted share price

NSE’s unlisted shares are currently changing hands at around Rs 1,970, according to data from Unlisted Arena. The shares were quoted at around Rs 2,010 when NSE filed its DRHP.
Over the past year, the unlisted stock has traded in a range of around Rs 1,800-2,150, well below its June 2025 peak of Rs 2,590.The shares had slipped to around Rs 1,950 on July 28-29 before recovering to current levels.

ALSO READ: NSE IPO coming soon: Should investors buy unlisted shares now or wait for the mega issue?

With NSE’s IPO expected in the second half of September, investors are now assessing whether to enter the stock through the unlisted market or wait for the public offering and its eventual listing.

How to buy NSE unlisted shares

NSE shares currently trade in the unlisted, over-the-counter market, where investors can acquire equity in companies ahead of their listing on recognised stock exchanges.

Unlike a listed stock, NSE’s unlisted shares do not have a continuous exchange-based price discovery mechanism or a live market price. Trades are negotiated privately between buyers and sellers, with the final transaction price depending on the prevailing quote and available liquidity.

Investors looking to acquire NSE shares can approach SEBI-registered investment banks, brokers or specialised unlisted-share dealers. These intermediaries facilitate transactions by matching investors seeking to buy pre-IPO shares with existing shareholders looking to sell.

Investors can also purchase shares directly from existing shareholders, including promoters, founders, angel investors and employees holding vested ESOPs. Such transactions are generally negotiated over the counter and may involve sizeable minimum ticket sizes.

Pre-IPO platforms also aggregate such opportunities and facilitate the KYC, price discovery and share-transfer process.

Step-by-step process to buy NSE unlisted shares

Choose an intermediary or platform: Register with a specialised unlisted-share platform or dealer offering NSE shares.

Complete KYC: Submit documents including PAN, Aadhaar, bank account details and the Client Master Report (CMR/CML) issued by your depository participant. The CMR contains details such as your demat account, DP ID, Client ID and linked bank account.

Check the quote and lot size: Unlike an exchange-traded stock, there is no central order book or exchange-determined price for NSE’s unlisted shares. Buyers and sellers negotiate the transaction price and quantity, with intermediaries facilitating the trade.

Place the order and make payment: Once the price and quantity are agreed upon, the buyer transfers funds through the payment channel specified by the platform, including UPI, NEFT, RTGS or a designated escrow account.

Complete the transfer documentation: Depending on the transaction, documentation may include the share purchase agreement (SPA), delivery instruction slip (DIS), proof of payment and transfer deed (SH-4).

Receive the shares in the demat account: Once the transaction is verified and the seller confirms the transfer, the shares are moved through an off-market transfer and credited to the buyer’s demat account through the depository system. The shares may typically be credited within 24 to 48 business hours, according to the details provided.

The two depositories, CDSL and NSDL, oversee the electronic transfer of shares. Proper documentation is critical to establishing the transfer of title, as unlisted transactions do not pass through the standard order-matching and settlement mechanism of a stock exchange.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)

This article was written by

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Lawrence Fuller is the Principal of Fuller Asset Management (FAM), a state registered investment adviser. He is also the manager of the Focused Growth portfolio on the copy-trading platform Dubapp.com. Information presented is for educational purposes only intended for a broad audience. The information does not intend to make an offer or solicitation for the sale of purchase of any specific securities, investments, or investment strategies. Investments involve risk and are not guaranteed. FAM has reasonable belief that this marketing does not include any false or material misleading statements or omissions of facts regarding services, investment, or client experience. FAM has reasonable belief that the content as a whole will not cause an untrue or misleading implication regarding the adviser’s services, investments, or client experiences. Past performance of specific investment advice should not be relied upon without knowledge of certain circumstances or market events, nature and timing of investments and relevant constraints of the investment. FAM has presented information in a fair and balanced manner. FAM is not giving tax, legal, or accounting advice.
Mr. Fuller may discuss and display charts, graphs, formulas, and stock picks which are not intended to be used by themselves to determine which securities to buy or sell, or when to buy or sell them. Such charts and graphs offer limited information and should not be used on their own to make investment decisions. Consultation with a licensed financial professional is strongly suggested. The opinions expressed herein are those of the firm and are subject to change without notice. The opinions referenced are as of the date of publication and are subject to change due to changes in market or economic conditions and may not necessarily come to pass.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Investors may not have made much money from the secondary market in August, with Nifty falling 0.6% during the month. But IPO investors had a far better run, as most new listings delivered gains on debut and continued to trade above their issue prices.

Out of 17 IPOs that listed in August, 15 gave positive listing-day returns, translating into a hit rate of about 88%. The same number of issues are also trading above their issue price as of the latest available data, which means nearly 90% of August IPOs are still in the green.

The performance shows that the primary market remained strong even as the broader secondary market stayed selective. Investor appetite was healthy across sectors such as healthcare, logistics, engineering, dairy, energy, jewellery, industrials and consumer-facing businesses.

Tempsens leads gains

Tempsens Instruments was the standout listing of the month. The company doubled investor money on debut, making it the biggest winner among August IPOs. Among others, Dhoot Transmission delivered the strongest current return. The stock was issued at Rs 871 and is now trading at Rs 1,499, giving investors a gain of 72%. It had already listed strongly at Rs 1,187, a listing-day gain of 36%.
Technocraft Ventures was another big winner. The stock listed at around Rs 311 against an issue price of Rs 212, giving a listing gain of 47%. It is now at Rs 358, up 69% from the issue price. Behari Lal Engineering also rewarded investors sharply. The stock listed at Rs 502 against an issue price of Rs 285, a gain of 76% on listing day. It is currently at Rs 469, still up 64% from the IPO price.

Also Read: Reliance Jio IPO: 7 risk factors investors should know as firm gets Sebi nod for Rs 37,000-crore issue
Milky Mist Dairy Food gave investors both listing gains and follow-up gains. The stock listed at Rs 181 against an issue price of Rs 140, a gain of around 30%. It has since moved to Rs 217.31, taking total gains to 56%.MV Electrosystems was another strong performer. It listed at Rs 624 against an issue price of Rs 425, a gain of 47%, and is currently at Rs 646.8, up 52%.

Most IPOs hold gains

Several IPOs that listed with decent gains continued to trade above issue price. Molbio Diagnostics is currently trading nearly 42% higher over the issue price, while Shiprocket is still up 37%. Manipal Health Enterprises also held firm after listing. The stock was issued at Rs 590, listed at Rs 667 and is now at Rs 798, giving investors a gain of 35%.

Only two IPOs turn negative

Only two August IPOs are currently below their issue prices. Shankesh Jewellers listed with a small gain of 2%, but has slipped below issue price and is trading about 4% lower. Horizon Industrial Parks had a weak debut, listing 3% below issue price, and is currently down 5%.

September pipeline remains strong

The strong August report card comes just as the IPO pipeline is set to get heavier in September. Investment banking sources expect more than 20 companies to tap the market during the month, with the total fundraising pipeline potentially going up to Rs 70,000 crore if one of the two mega issues, Jio Platforms or NSE, is launched.

Jio Platforms has already received Sebi approval for its much-awaited IPO. The Reliance Industries-backed digital services company is expected to raise around Rs 37,700 crore, which could make it one of India’s largest-ever public issues. NSE is also likely to receive Sebi approval soon and may launch its IPO as early as September, according to people aware of the matter. The exchange’s tentative issue size is pegged at around Rs 30,000 crore.

The pick-up follows a busy July and August for the primary market. Companies raised about Rs 28,000 crore in July and more than Rs 23,000 crore in August, showing that issuers have returned after holding back during the volatile first half of the year.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)